Medicine and Dentistry
Head and Neck Squamous Cell Carcinoma
100%
Neck
95%
Evaluation Study
76%
Programmed Cell Death
76%
Newborn Morbidity
76%
Artificial Respiration
76%
Childbirth
76%
Patent Ductus Arteriosus
76%
Squamous Cell Carcinoma
76%
Programmed Death 1 Ligand 1
76%
Antidiabetic Agent
50%
Pembrolizumab
38%
Tissue Microarray
38%
Neoplasm
30%
Blood Glucose
25%
Prospective Cohort Study
25%
Respiratory Failure
25%
Pathologist
19%
Diagnostic Test
19%
Aortic Aneurysm Endovascular Graft
19%
Funnel Plot
5%
Immunology and Microbiology
Programmed Death 1 Ligand 1
76%
Gamma Urogastrone
76%
Newborn Morbidity
76%
Ductus Arteriosus
76%
Squamous Cell
76%
Neck
76%
Cell Line
34%
Glucose Blood Level
25%
Videorecording
25%
Immunology
13%
Artificial Intelligence
6%
Keyphrases
Inter-laboratory Variation
76%
Programmed Death-ligand 1 (PD-L1)
76%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
76%
Netherlands
76%
Assay Reliability
76%
Positivity Rate
23%
Abnormal Blood Glucose
19%
Combined Positive Score
17%
DG44
13%
Tumor
11%
Dutch
11%
Funnel Plot
5%
Pathology Report
5%
Recurrent or Metastatic
5%
Test Standardization
5%
AIMS™
5%
Immune Checkpoint Inhibitors
5%
Confidence Limits
5%
22C3 Antibody
5%
